| 000 | 01631 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250510214043.0 | ||
| 264 | 0 | _c19750913 | |
| 008 | 197509s 0 0 eng d | ||
| 022 | _a0090-1229 | ||
| 024 | 7 |
_a10.1016/0090-1229(75)90058-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWebb, D R | |
| 245 | 0 | 0 |
_aControl of mitogen-induced lymphocyte activation. 11. Analysis of cell populations and metabolic events involved in cyclic AMP-mediated recovery of DNA synthesis suppressed by mitogens. _h[electronic resource] |
| 260 |
_bClinical immunology and immunopathology _cJul 1975 |
||
| 300 |
_a226-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aCalcium _xdeficiency |
| 650 | 0 | 4 | _aCations, Divalent |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP _xanalysis |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGlucuronidase _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aLymphocytes _xmetabolism |
| 650 | 0 | 4 |
_aMitogens _xpharmacology |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
| 650 | 0 | 4 |
_aThymidine _xmetabolism |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aBelohradsky, B | |
| 700 | 1 | _aHanes, D | |
| 700 | 1 | _aStites, D P | |
| 700 | 1 | _aPerlman, J D | |
| 700 | 1 | _aFudenberg, H H | |
| 773 | 0 |
_tClinical immunology and immunopathology _gvol. 4 _gno. 2 _gp. 226-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-1229(75)90058-6 _zAvailable from publisher's website |
| 999 |
_c163936 _d163936 |
||